Geneva, June 22 -- International Clinical Trials Registry received information related to the study (EUCTR2025-000101-16-Outside-EU/EEA) titled 'A Study to Learn About How a New Pneumococcal Vaccine Works in Children' on June 10.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: yes Randomised: yes Open: no Single blind: no Double blind: yes Parallel group: yes Cross over: no Other: yes Other trial design description: Study is partially blinded as 2 of the 3 groups are blinded and 1 is unblinded If controlled, specify comparator, Other Medicinial Product: yes Placebo: no Other: no Number of treatment arms in the trial: 3
Primary Sponsor: Pfizer, Inc
Condition:
Pneumococcal Disease
Therapeutic a...